Global head CMC strategy & execution, mRNA CoE
Sanofi
Maria Teresa Peracchia is the Global Head of CMC Strategy & Execution in the Sanofi mRNA Center of Excellence, leading the CMC Project Leaders team and in charge of designing and aligning the End-to-End CMC strategy for the mRNA vaccine portfolio.
Maria-Teresa holds a Ph.D. in Pharmaceutics from the University of Parma, Italy. During her PhD, supervised by Professor Paolo Colombo, she was a Visiting Scientist (1992-1994) in Professor Robert Langer’s lab at MIT, developing PEGylated polymeric nanoparticles. She was a post-doctoral fellow (1995-1998) with Prof. Patrick Couvreur at the University Paris-Saclay, focusing her work on the design of new PEGylated nanoparticles from polymer chemistry to in vivo biodistribution. During her PhD and postdoc, she has authored/ co-authored over 20 publications in the field of drug delivery and filed 8 patents.
Maria Teresa joined Sanofi in 1999. She held several positions of increasing responsibility in formulation development, drug delivery and CMC project management. From 2013 to 2019, she served as CMC Project Leader for Dupilumab (Dupixent®) developed in collaboration with Regeneron, where she led the CMC team through successful submission, registration and launch of Dupilumab for Atopic Dermatitis and Asthma indications.
Disclosure information not submitted.
Translational Research Panel: Advancing Discoveries from the Research Bench to the Clinic
Thursday, July 17, 2025
3:00 PM - 4:00 PM EDT
Industry Achievement Award Presentation
Thursday, July 17, 2025
3:00 PM - 3:10 PM EDT
